Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Alfresa Holdings Corporation was established in 1984 by Yoshinori Kagawa and began operating in 1986. Yoshinori Kagawa's commitment to innovation, quality, and customer service has led the company through a period of extensive growth and success. Alfresa is a leader in the fields of pharmaceuticals, medical devices, retail pharmacy and dietary supplements.
Our mission is to improve the lives of people in Japan and around the world by providing high-quality, innovative and affordable healthcare products and services.
To be the world’s most trusted and respected healthcare company by providing our customers with safe, reliable and cost-effective healthcare products and services.
Read More:
best free ai business plan generator
